Pseudoxanthoma elasticum epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Pseudoxanthoma elasticum}} {{SI}} {{CMG}}; {{AE}} {{AO}} ==Overview== ==Epidemiology and Demographics== The reported prevalence of pseudoxanthoma elasticum is ab..." |
No edit summary |
||
Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The | PXE is a rare disease but the exact prevalence is unknown. The prevalence has been suggested to be approximately 1:50,000,<ref name="Uitto-2012">{{Cite journal | last1 = Uitto | first1 = J. | title = Rare heritable skin diseases: targets for regenerative medicine. | journal = J Invest Dermatol | volume = 132 | issue = 11 | pages = 2485-8 | month = Nov | year = 2012 | doi = 10.1038/jid.2012.334 | PMID = 23069901 }}</ref> with an estimate of 150,000 affected in the world assuming the same global prevalence.<ref name="Uitto-2012">{{Cite journal | last1 = Uitto | first1 = J. | title = Rare heritable skin diseases: targets for regenerative medicine. | journal = J Invest Dermatol | volume = 132 | issue = 11 | pages = 2485-8 | month = Nov | year = 2012 | doi = 10.1038/jid.2012.334 | PMID = 23069901 }}</ref> Females are twice as likely to be affected as males. The disease occurs in all ethnicities, but South Africans are more likely to have PXE as a result of a [[founder effect]] (i.e. it was relatively prevalent in the small group of people from whom most South Africans descend).<ref name="Allen-1992">{{Cite journal | last1 = Allen | first1 = P. | last2 = Wightman | first2 = F. | title = Spectral pattern discrimination by children. | journal = J Speech Hear Res | volume = 35 | issue = 1 | pages = 222-33 | month = Feb | year = 1992 | doi = | PMID = 1735972 }}</ref> | ||
==References== | ==References== |
Revision as of 23:36, 18 August 2013
Pseudoxanthoma elasticum Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pseudoxanthoma elasticum epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Pseudoxanthoma elasticum epidemiology and demographics |
FDA on Pseudoxanthoma elasticum epidemiology and demographics |
Pseudoxanthoma elasticum epidemiology and demographics in the news |
Blogs on Pseudoxanthoma elasticum epidemiology and demographics |
Risk calculators and risk factors for Pseudoxanthoma elasticum epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Overview
Epidemiology and Demographics
PXE is a rare disease but the exact prevalence is unknown. The prevalence has been suggested to be approximately 1:50,000,[1] with an estimate of 150,000 affected in the world assuming the same global prevalence.[1] Females are twice as likely to be affected as males. The disease occurs in all ethnicities, but South Africans are more likely to have PXE as a result of a founder effect (i.e. it was relatively prevalent in the small group of people from whom most South Africans descend).[2]
References
- ↑ 1.0 1.1 Uitto, J. (2012). "Rare heritable skin diseases: targets for regenerative medicine". J Invest Dermatol. 132 (11): 2485–8. doi:10.1038/jid.2012.334. PMID 23069901. Unknown parameter
|month=
ignored (help) - ↑ Allen, P.; Wightman, F. (1992). "Spectral pattern discrimination by children". J Speech Hear Res. 35 (1): 222–33. PMID 1735972. Unknown parameter
|month=
ignored (help)